Dachaigh › Galar Depressive Mòr › Illinois › Chicago
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Chicago, IL
Tha 17 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
A’ fastadhÌre 3
- Charter Research - Chicago, Chicago
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
A’ fastadhÌre 3
- Chicago Research Center, Chicago
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
A’ fastadhÌre 3
- Northwestern University, Chicago
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
A’ fastadhÌre 2
- Chicago Research Center, Chicago
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
A’ fastadhÌre 3
- Rush University, Chicago
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
A’ fastadhÌre 3
- Vanda Investigational Site, Chicago
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
A’ fastadhÌre 2
- Draig Clinical Site, Chicago
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
A’ fastadh
- Rush University Medical Center, Chicago
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
A’ fastadhÌre 3
- Uptown Research Institute, Chicago
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A’ fastadhÌre 2
- EmVenio Research, Chicago
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
A’ fastadhÌre 3
- Clinical Research Site, Chicago
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A’ fastadhÌre 2
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
A’ fastadh
- University of Illinois at Chicago, Chicago
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
A’ fastadhÌre 2
- Pillar Clinical Research LLC, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
A’ fastadhSgrùdadh amharc
- University of Chicago Medical Center, Chicago
Study of ALTO-300 in MDD
A’ fastadhÌre 2
- Site 310, Chicago
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
A’ fastadhÌre 4
- Clinical Research Site, Chicago
Sgrùdaidhean Galar Depressive Mòr ann am bailtean eile
- New York City, NY37 sgrùdaidhean
- Boston, MA31 sgrùdaidhean
- Atlanta, GA25 sgrùdaidhean
- Philadelphia, PA23 sgrùdaidhean
- Orlando, FL19 sgrùdaidhean
- Miami, FL18 sgrùdaidhean
- Tampa, FL17 sgrùdaidhean
- Houston, TX16 sgrùdaidhean
- San Diego, CA16 sgrùdaidhean
- Little Rock, AR14 sgrùdaidhean
- Austin, TX13 sgrùdaidhean
- Orange, CA13 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach58 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Cancer Ovarian36 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Aillse colorectal33 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm28 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.